Browse studies
Find your next paid study
4 recruiting studies matching your filters
Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia - A Prospective Observational Cohort Study - IBIS XLH
The purpose of this study is to better understand how X-linked hypophosphatemia (XLH) affects the body and daily life. Phosphate levels are critical in managin…
X-linked Hypophosphatemia (XLH)
Estimated
~$10 – $1,125
Novo Nordisk A/SNCT07607600
Phase 2
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
The primary goal is to determine if Dipyridamole can improve serum phosphate levels and reduce the need for phosphate supplementation.
HypophosphatemiaKidney Transplantation
Estimated
~$10 – $6,250
Stanford UniversityNCT06824454
Phase 1
The Impact of Phosphate Metabolism on Healthy Aging
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…
HypophosphatemiaRicketsHypercalciuria+2 more
Estimated
~$10 – $6,250
Yale UniversityNCT03771105
Phase 1
A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
X-linked Hypophosphatemia
Estimated
~$10 – $8,750
Kyowa Kirin Co., Ltd.NCT06525636